Prevalence of HER2 low in breast cancer subtypes using the VENTANA anti-HER2/neu (4B5) assay.

Marietta Scott,Michel Erminio Vandenberghe,Paul Scorer,Anne-Marie Boothman,Craig Barker

Prevalence of HER2 low in breast cancer subtypes using the VENTANA anti-HER2/neu (4B5) assay.

2021

Marietta Scott
Michel Erminio Vandenberghe
Paul Scorer
Anne-Marie Boothman
Craig Barker

1021Background: Breast cancer patients with HER2 low expression by immunohistochemistry (IHC), defined as IHC1+ or IHC2+ without gene amplification (ISH-) do not respond to conventional anti-HER2 t...

Keywords:

Cancer research
Immunohistochemistry
Medicine
anti her2
Breast cancer
Gene duplication

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations